OKYO Pharma Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for OKYO Pharma Limited (OKYO) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
Operating Activities
Net Income-7.97-16.83-13.27-5.43-2.46-1.27-3.76-20.17
Depreciation & Amortization0.000.000.000.000.010.000.000.00
Stock Based Compensation0.731.131.291.800.630.000.000.00
Change in Working Capital3.632.673.95-1.020.760.130.140.03
Change in Accounts Receivable-0.090.000.000.030.000.000.000.00
Change in Accounts Payable0.002.233.78-0.250.840.000.000.00
Change in Other Working Capital3.720.440.11-0.800.210.000.000.00
Other Operating Activities1.803.530.11-0.810.060.032.060.18
Net Cash from Operating Activities-1.81-9.49-7.70-5.47-1.16-0.96-1.53-1.14
Investing Activities
Capital Expenditures0.000.00-0.010.00-0.010.000.000.00
Other Investing Activities0.000.000.000.00-0.010.000.000.00
Net Cash from Investing Activities0.000.00-0.010.00-0.01-0.100.000.00
Financing Activities
Debt Repayment0.950.000.000.000.000.000.000.00
Common Stock Issued1.716.217.322.150.170.780.000.00
Other Financing Activities0.000.000.000.000.000.000.000.00
Net Cash from Financing Activities2.666.219.322.155.690.770.000.00
Summary
Effect of Forex Changes on Cash-0.110.06-0.28-0.870.320.000.000.00
Net Change in Cash0.73-3.221.62-4.194.84-0.29-1.53-1.14
Cash at Beginning of Period0.834.052.706.890.170.482.013.15
Cash at End of Period1.560.834.05-3.325.010.190.482.01
Free Cash Flow-1.81-9.49-7.70-5.47-1.61-1.07-1.53-53.05
Supplemental Disclosures
Income Taxes Paid-2.000.00-0.200.00-0.080.000.000.00